- Home
- DCTH vs BCAL Comparison
DCTH vs BCAL Comparison
Compare DCTH & BCAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- BCAL
- Stock Information
- Founded
- DCTH 1988
- BCAL 2001
- Country
- DCTH United States
- BCAL United States
- Employees
- DCTH N/A
- BCAL N/A
- Industry
- DCTH Medical/Dental Instruments
- BCAL Major Banks
- Sector
- DCTH Health Care
- BCAL Finance
- Exchange
- DCTH Nasdaq
- BCAL Nasdaq
- Market Cap
- DCTH 630.4M
- BCAL 478.1M
- IPO Year
- DCTH N/A
- BCAL N/A
- Fundamental
- Price
- DCTH $16.21
- BCAL $14.94
- Analyst Decision
- DCTH Strong Buy
- BCAL Strong Buy
- Analyst Count
- DCTH 4
- BCAL 1
- Target Price
- DCTH $24.00
- BCAL $20.00
- AVG Volume (30 Days)
- DCTH 610.5K
- BCAL 81.1K
- Earning Date
- DCTH 05-08-2025
- BCAL 07-28-2025
- Dividend Yield
- DCTH N/A
- BCAL N/A
- EPS Growth
- DCTH N/A
- BCAL N/A
- EPS
- DCTH N/A
- BCAL 0.62
- Revenue
- DCTH $53,850,000.00
- BCAL $132,045,000.00
- Revenue This Year
- DCTH $141.47
- BCAL $74.16
- Revenue Next Year
- DCTH $49.31
- BCAL $4.92
- P/E Ratio
- DCTH N/A
- BCAL $23.94
- Revenue Growth
- DCTH 1068.87
- BCAL 42.63
- 52 Week Low
- DCTH $6.33
- BCAL $11.87
- 52 Week High
- DCTH $18.23
- BCAL $18.49
- Technical
- Relative Strength Index (RSI)
- DCTH 58.15
- BCAL 55.07
- Support Level
- DCTH $16.02
- BCAL $14.50
- Resistance Level
- DCTH $17.29
- BCAL $15.27
- Average True Range (ATR)
- DCTH 0.99
- BCAL 0.47
- MACD
- DCTH -0.03
- BCAL -0.05
- Stochastic Oscillator
- DCTH 49.63
- BCAL 39.64
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About BCAL Southern California Bancorp
California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.